Search Login Register

gemcitabine Summary

Description: structure given in first source; RN given refers to (D-erythro)-isomer

Also Known As: 2',2'-DFDC; 2',2'-difluoro-2'-deoxycytidine; 2',2'-difluorodeoxycytidine; 2'-deoxy-2',2''-difluorocytidine-5'-O-monophosphate; 2'-deoxy-2'-difluorocytidine Show All >>

Networked: 7642 relevant articles (1204 outcomes, 3120 trials/studies) for this Drug

Key Diseases for which gemcitabine is Relevant

  1. Pancreatic Neoplasms (Pancreatic Cancer) : 349 outcomes 783 studies in 2171 results
  2. Neoplasms (Cancer) : 242 outcomes 572 studies in 2251 results
  3. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) : 167 outcomes 638 studies in 1171 results
  4. Breast Neoplasms (Breast Cancer) : 96 outcomes 238 studies in 462 results
  5. Carcinoma (Carcinomatosis) : 71 outcomes 225 studies in 671 results
Show All >>

Drugs Related to gemcitabine

  1. Cisplatin (Platino)
  2. Paclitaxel (Taxol)
  3. docetaxel (Taxotere)
  4. Carboplatin (JM8)
  5. Fluorouracil (Carac)
  6. vinorelbine (Navelbine)
  7. oxaliplatin (Eloxatin)
  8. Platinum
  9. erlotinib (CP 358,774)
  10. gemcitabine
Show All >>

Therapies Related to gemcitabine

  1. Drug Therapy (Chemotherapy)
  2. Combination Drug Therapy (Combination Chemotherapy)
  3. Heterologous Transplantation (Xenotransplantation)
  4. Radiotherapy
  5. Adjuvant Chemotherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.